Transdisciplinary sarcoma care: a model for sustainable healthcare transformation

Fuchs, Bruno; Bode, Beata; Heesen, Philip; Kopf, Barbara; Michelitsch, Christian; Odermatt, Manfred; Giovanoli, Pietro; Breitenstein, Stefan; Schneider, Paul; Schüpfer, Guido; Boes, Stefan; Studer, Gabriela

doi:10.57187/s.3473

Cited by 4 publications

(1 citation statement)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Despite clinical advancements, the economic aspects of these treatments, particularly cost variability across different healthcare settings, are underexplored [ 5 , 6 , 10 ]. Most studies focus on clinical efficacy, often neglecting the substantial economic burdens these treatments impose [ 11 , 12 ]. Our study fills this gap by providing a detailed comparison of surgical and hospital costs and analyzing how institutional characteristics and surgical complexities impact healthcare economics.…”

Section: Introductionmentioning

confidence: 99%

Impact of Institutional Practices and Surgical Complexity on Sarcoma Surgery Costs: Driving Efficiency in Value-Based Healthcare

Schelling,

Heesen,

Tautermann

et al. 2024

Cancers

Self Cite

View full text Add to dashboard Cite

Background: Sarcomas present a unique challenge within healthcare systems due to their rarity and complex treatment requirements. This study explores the economic impact of sarcoma surgeries across three Swiss tertiary healthcare institutions, utilizing a consistent surgical approach by a single surgeon to eliminate variability in surgical expertise as a confounding factor. Methods: By analyzing data from 356 surgeries recorded in a real-world-time data warehouse, this study assesses surgical and hospital costs relative to institutional characteristics and surgical complexity. Results: Our findings reveal significant cost variations driven more by institutional resource management and pricing strategies than by surgical techniques. Surgical and total hospitalization costs were analyzed in relation to tumor dignity and complexity scores, showing that higher complexity and malignancy significantly increase costs. Interestingly, it was found that surgical costs accounted for only one-third of the total hospitalization costs, highlighting the substantial impact of non-surgical factors on the overall cost of care. Conclusions: The study underscores the need for standardized cost assessment practices and highlights the potential of predictive models in enhancing resource allocation and surgical planning. By advocating for value-based healthcare models and standardized treatment guidelines, this research contributes to more equitable and sustainable healthcare delivery for sarcoma patients. These insights affirm the necessity of including a full spectrum of care costs in value-based models to truly optimize healthcare delivery. These insights prompt a reevaluation of current policies and encourage further research across diverse geographical settings to refine cost management strategies in sarcoma treatment.

show abstract

Section: Introductionmentioning

confidence: 99%

Impact of Institutional Practices and Surgical Complexity on Sarcoma Surgery Costs: Driving Efficiency in Value-Based Healthcare

Schelling,

Heesen,

Tautermann

et al. 2024

Cancers

Self Cite

View full text Add to dashboard Cite

show abstract

Beyond the sarcoma center: establishing the Sarcoma HASM network—a Hub and Spoke Model network for global integrated and precision care

Fuchs,

Gronchi

2024

ESMO Open

View full text Add to dashboard Cite

Real-World-Time Data and RCT Synergy: Advancing Personalized Medicine and Sarcoma Care through Digital Innovation

Heesen,

Schelling,

Birbaumer

et al. 2024

Cancers

View full text Add to dashboard Cite

This manuscript examines the synergistic potential of prospective real-world/time data/evidence (RWTD/E) and randomized controlled trials (RCTs) to enrich healthcare research and operational insights, with a particular focus on its impact within the sarcoma field. Through exploring RWTD/E’s capability to provide real-world/time, granular patient data, it offers an enriched perspective on healthcare outcomes and delivery, notably in the complex arena of sarcoma care. Highlighting the complementarity between RWTD/E’s expansive real-world/time scope and the structured environment of RCTs, this paper showcases their combined strength, which can help to foster advancements in personalized medicine and population health management, exemplified through the lens of sarcoma treatment. The manuscript further outlines methodological innovations such as target trial emulation and their significance in enhancing the precision and applicability of RWTD/E, underscoring the transformative potential of these advancements in sarcoma care and beyond. By advocating for the strategic incorporation of prospective RWTD/E into healthcare frameworks, it aims to create an evidence-driven ecosystem that significantly improves patient outcomes and healthcare efficiency, with sarcoma care serving as a pivotal domain for these developments.

show abstract

Transdisciplinary sarcoma care: a model for sustainable healthcare transformation

Abstract: No abstract available.

Cited by 4 publications

References 14 publications

Impact of Institutional Practices and Surgical Complexity on Sarcoma Surgery Costs: Driving Efficiency in Value-Based Healthcare

Impact of Institutional Practices and Surgical Complexity on Sarcoma Surgery Costs: Driving Efficiency in Value-Based Healthcare

Beyond the sarcoma center: establishing the Sarcoma HASM network—a Hub and Spoke Model network for global integrated and precision care

Real-World-Time Data and RCT Synergy: Advancing Personalized Medicine and Sarcoma Care through Digital Innovation

Contact Info

Product

Resources

About